- Home
- RF vs PODD Comparison
RF vs PODD Comparison
Compare RF & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RF
- PODD
- Stock Information
- Founded
- RF 1970
- PODD 2000
- Country
- RF United States
- PODD United States
- Employees
- RF N/A
- PODD N/A
- Industry
- RF Major Banks
- PODD Medical/Dental Instruments
- Sector
- RF Finance
- PODD Health Care
- Exchange
- RF Nasdaq
- PODD Nasdaq
- Market Cap
- RF 19.2B
- PODD 21.5B
- IPO Year
- RF N/A
- PODD 2007
- Fundamental
- Price
- RF $27.09
- PODD $331.83
- Analyst Decision
- RF Buy
- PODD Strong Buy
- Analyst Count
- RF 17
- PODD 18
- Target Price
- RF $26.88
- PODD $332.22
- AVG Volume (30 Days)
- RF 15.2M
- PODD 697.4K
- Earning Date
- RF 10-17-2025
- PODD 08-07-2025
- Dividend Yield
- RF 3.91%
- PODD N/A
- EPS Growth
- RF 20.30
- PODD N/A
- EPS
- RF 2.14
- PODD 3.32
- Revenue
- RF $6,811,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- RF $17.72
- PODD $24.54
- Revenue Next Year
- RF $3.97
- PODD $17.48
- P/E Ratio
- RF $12.65
- PODD $99.86
- Revenue Growth
- RF 3.31
- PODD 26.00
- 52 Week Low
- RF $17.74
- PODD $180.31
- 52 Week High
- RF $27.96
- PODD $334.18
- Technical
- Relative Strength Index (RSI)
- RF 68.75
- PODD 68.39
- Support Level
- RF $25.55
- PODD $327.17
- Resistance Level
- RF $26.01
- PODD $334.18
- Average True Range (ATR)
- RF 0.52
- PODD 8.48
- MACD
- RF 0.11
- PODD 2.55
- Stochastic Oscillator
- RF 98.82
- PODD 95.05
About RF Regions Financial Corporation
Regions Financial is a regional bank based in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.